KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Treasury Shares (2016 - 2025)

Resmed (RMD) has disclosed Treasury Shares for 16 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 26.45% year-over-year to $2.4 billion, compared with a TTM value of $2.4 billion through Dec 2025, up 26.45%, and an annual FY2025 reading of $2.1 billion, up 16.92% over the prior year.
  • Treasury Shares was $45.2 million for Q4 2025 at Resmed, up from $44.4 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $45.2 million in Q4 2025 and bottomed at $222000.0 in Q3 2024.
  • Average Treasury Shares over 5 years is $40.4 million, with a median of $41.8 million recorded in 2021.
  • The sharpest move saw Treasury Shares changed 0.0% in 2021, then grew 26.45% in 2025.
  • Year by year, Treasury Shares stood at $1.6 billion in 2021, then changed by 0.0% to $1.6 billion in 2022, then grew by 3.08% to $1.7 billion in 2023, then rose by 13.45% to $1.9 billion in 2024, then rose by 26.45% to $2.4 billion in 2025.
  • Business Quant data shows Treasury Shares for RMD at $2.4 billion in Q4 2025, $2.2 billion in Q3 2025, and $2.1 billion in Q2 2025.